-
-
-
-
-
-
-
Tempus expands AI platform to six new cancer types for clinical insights
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $68 at TD Cowen
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $95 at H.C. Wainwright
-
-
-
-
-
-
-
Baird Starts Tempus AI Inc (TEM) at Outperform
-
-
-
-
-
-
-
Tempus presents eight research abstracts at ASCO GI symposium
-
-
-
-
-
-
-
Tempus AI (TEM) call put ratio 1.4 calls to 1 put into quarter results
-
-
-
-
-
-
-
Renalytix partners with Tempus AI to expand kidney disease testing
-
413,534 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

